Topics

Articles

Are Pharma Brands Worth Protecting?

Just as the pharma industry is feeling price and margin pressure, so are wholesalers in today’s healthcare marketplace

Forces of Change for Pharmaceutical Wholesalers

Both promise and peril exist for drugmakers in working with diagnostic tests to commercialize new medications or refine the applicability of existing ones

How to Think About Companion Diagnostics

Mid-Course Corrections for REMS

Not all managed care plans have the same influence on overall prescribing behavior, and not all geographies operate the same way

The Time Is Right to Reform Your Approach to Managed Care

More personal control over healthcare and the desire for more access to information drive consumer attitudes

Deloitte 2010 Survey of Health Care Consumers

Court rulings begin to swing toward categorizing pharma reps as hourly workers

Today's Sales Reps: Medical Professionals, Order Takers, Delivery Staff--or Something Else?

Small Distributors Serve a Vital Role in the Pharmaceutical Distribution Supply Chain

The biopharma company’s annual report provides clarity to a confusing marketplace

Spotlight on the EMD Serono Specialty Digest, 6th Edition

Following are excerpts from the keynote presentation of Steven C. Anderson, president and CEO of the National Assn. of Chain Drug Stores, at its annual meeting, Palm Beach, FL, Apr. 25.

Opinion